Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Nu Holdings
NU
5
Liberty Latin America-A
LILA
CN Stock MarketDetailed Quotes
301096 Hangzhou Bio-Sincerity Pharma-Tech
- 33.00
- +0.53+1.63%
Market Closed Apr 25 15:00 CST
3.60BMarket Cap-27.99P/E (TTM)
33.12High31.88Low28.56KlotVolume32.60Open32.47Pre Close93.10MTurnover4.11%Turnover RatioLossP/E (Static)109.23MShares73.2252wk High1.41P/B2.29BFloat Cap30.6052wk Low38.96Limit Up69.43MShs Float118.30Historical High25.98Limit Down3.82%Amplitude30.60Historical Low0.30Dividend TTM32.59Avg Price10.17KlotAsk0.91%Div YieldTTM100Lot Size17.48KlotBid
Hangzhou Bio-Sincerity Pharma-Tech Key Stats
EPS
According to the latest financial report of Hangzhou Bio-Sincerity Pharma-Tech, the latest earnings per share (TTM) for the company is -0.24. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Hangzhou Bio-Sincerity Pharma-Tech's latest financial report to see how much their book value per share (BVPS) is currently at 23.37.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Hangzhou Bio-Sincerity Pharma-Tech shows that the company's current ratio is 1.90, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Hangzhou Bio-Sincerity Pharma-Tech, the quick ratio is 1.67, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Hangzhou Bio-Sincerity Pharma-Tech? The latest ROE figure is -1.02%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Hangzhou Bio-Sincerity Pharma-Tech, the total asset return on investment (ROA) is -0.70%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Hangzhou Bio-Sincerity Pharma-Tech's latest financial report to see how their gross margin is doing - currently at 41.62%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Hangzhou Bio-Sincerity Pharma-Tech, the net profit margin is -20.35%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs